Continuous response of certolizumab pegol in the treatment of patients with plaque-psoriasis: results from the two multicenter, randomized, placebo-controlled Phase-3-Studies (CIMPASI-1 and CIMPASI-2)
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
2018
Journal Title
Journal Der Deutschen Dermatologischen Gesellschaft
Department
Dermatology
Recommended Citation
Reich, K., & Gottlieb, A. B. (2018). Continuous response of certolizumab pegol in the treatment of patients with plaque-psoriasis: results from the two multicenter, randomized, placebo-controlled Phase-3-Studies (CIMPASI-1 and CIMPASI-2). Journal Der Deutschen Dermatologischen Gesellschaft, 16 (Suppl. 1), 14-15. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/350
COinS
Comments
Please see the work itself for a complete list of authors